United Therapeutics SG&A Expense (Quarterly) Trends

United Therapeutics Corp (UTHR)

260.51 -1.89 (-0.72%) USD | NASDAQ | May 06, 16:00

260.51 0.00 (0.00%) Pre-Market: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 1999. Upgrade now.

Date	Value
March 31, 2024	144.40M
December 31, 2023	132.20M
September 30, 2023	127.60M
June 30, 2023	130.00M
March 31, 2023	87.30M
December 31, 2022	163.20M
September 30, 2022	98.40M
June 30, 2022	141.50M
March 31, 2022	79.00M
December 31, 2021	127.90M
September 30, 2021	109.10M
June 30, 2021	112.80M
March 31, 2021	117.20M
December 31, 2020	158.70M
September 30, 2020	66.30M
June 30, 2020	105.90M
March 31, 2020	93.00M
December 31, 2019	105.20M
September 30, 2019	99.40M
June 30, 2019	39.60M
March 31, 2019	92.00M
December 31, 2018	79.20M
September 30, 2018	110.10M
June 30, 2018	83.10M
March 31, 2018	-6.60M

Date	Value
December 31, 2017	159.10M
September 30, 2017	47.20M
June 30, 2017	67.40M
March 31, 2017	56.40M
December 31, 2016	139.50M
September 30, 2016	100.10M
June 30, 2016	72.20M
March 31, 2016	5.00M
December 31, 2015	148.70M
September 30, 2015	-17.30M
June 30, 2015	110.00M
March 31, 2015	211.30M
December 31, 2014	80.55M
September 30, 2014	202.51M
June 30, 2014	68.03M
March 31, 2014	30.22M
December 31, 2013	157.18M
September 30, 2013	94.11M
June 30, 2013	71.36M
March 31, 2013	71.36M
December 31, 2012	40.07M
September 30, 2012	68.63M
June 30, 2012	53.26M
March 31, 2012	39.79M
December 31, 2011	57.71M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

39.60M

Minimum

Jun 2019

163.20M

Maximum

Dec 2022

111.94M

Average

110.95M

Median

SG&A Expense (Quarterly) Benchmarks